Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.04	48.40	75.67
Graham Fair Price	489.77	8.37	1.42
PEG	-99.89	< 0.005	-4.97
Price/Book	-2.00	2.82	2.88
Price/Cash Flow	8.27	-776.31	717.04
Prices/Earnings	-96.66	16.07	481.62
Price/Sales	-21.59	9.88	12.60
Price/FCF	8.27	-776.31	717.04
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-26.26	0.38	0.51
Operating Margin	319.77	0.19	0.05
ROA	2719.12	0.03	< 0.005
ROE	< 0.005	0.04	2837.34
ROIC	< 0.005	0.04	1016.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.12	-0.09	1174.56
Dividends QOQ	-0.68	-0.25	62.77
EBIT QOQ	-0.82	4.60	459.92
EPS QOQ	-0.97	30.36	3035.59
FCF QOQ	-0.86	-1.97	-128.22
Revenue QOQ	-0.40	0.33	-16.28
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	104.81	61.53	-41.30
Days Sales Outstanding (DSO)	86.68	66.92	-22.79
Inventory Turnover	0.86	1.46	70.35
Debt/Capitalization	0.12	0.21	77.96
Quick Ratio	1.08	1.74	60.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.74	8.43	8.82
Cash	1.74	2.97	70.48
Capex	-0.11	-0.12	-13.13
Free Cash Flow	0.03	-0.03	-1.50
Revenue	1.77	2.40	36.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.48	2.21	48.89
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.53	-1.66	34.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating